Overview


According to FutureWise analysis the market for crohn's disease in 2023 is US$ 11.54 billion, and is expected to reach US$ 15.69 billion by 2031 at a CAGR of 3.92%.

IBDs include inflammatory bowel diseases like Crohn's disease. It causes the tissues in the digestive tract to enlarge (inflamed), which can result in abdominal pain, exhaustion, weight loss, severe diarrhea, and malnutrition. Individuals may experience inflammation linked to Crohn's disease in different areas of the digestive tract, most frequently the small intestine. Often, this inflammation affects the deeper layers of the bowel. Sometimes the effects of Crohn's disease might be fatal, uncomfortable, or disabling. Even though there is no known treatment for Crohn's disease, drugs can significantly lessen its signs and symptoms, even produce long-term remission, and even cause inflammation to heal. Numerous individuals with Crohn's disease may lead productive lives if they're given the right care.

The majority of Crohn's disease patients lead active, healthy lives. Although there is no known cure for Crohn's disease, medications, and lifestyle adjustments can prolong remission and reduce complications. Dietary changes are a type of lifestyle change. Crohn's disease patients frequently need to modify their diets to receive adequate daily calories. For those who have Crohn's disease, lactose intolerance might be problematic. If an individual discovers they are having problems with this food intolerance, they may need to avoid some dairy products. Following a Crohn's disease diagnosis, the doctor may advise the patient to have routine preventive colonoscopies.

FutureWise Market Research has published a report that provides an insightful analysis of Crohn’s disease market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the Crohn’s disease market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Johnson & Johnson Services Inc
  • Pfizer Inc
  • Allergan
  • AbbVie Inc
  • Bayer AG
  • Amgen, Inc.
  • Takeda Pharmaceutical Company Limited,
  • UCB S.A
  • Ferring B.V.
  • Eli Lilly and Company
  • Hoffman-La Roche
  • Bristol-Myers Squibb
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Janssen Biotech, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Crohn’s Disease Market:

In April 2022- The Crohn's and Colitis Foundation granted project funding to Microbiotica as a part of its inflammatory bowel disease ventures program for the creation of inflammatory bowel disease treatments.

The phrase "inflammatory bowel disease" (IBD) refers to illnesses, most frequently Crohn's disease, that cause ongoing, non-infectious digestive system inflammation. IBD can negatively impact all facets of an individual’s life. Inflammatory bowel disease (IBD) is becoming more common worldwide, and levels and trends in the disease fluctuate greatly across various countries and regions. This could significantly increase the social and financial burden on governments and healthcare systems during the forecast period. IBD is growing increasingly in Western countries, and its prevalence is rapidly increasing in recently developed nations. It indicates that the Westernisation of environments and foods, which affects the gut flora and increases the risk of IBD in people with specific genetic predispositions, is related to the global rise in IBD. The market for Crohn's disease is anticipated to grow during forecast period due to the rise in IBD prevalence. Moreover, a robust product pipeline and projected launches are expected to fuel market growth. Modern therapies focus on reducing inflammation, the risk of complications, and long-lasting remission. Hospitals and other healthcare organizations work closely with pharmaceutical companies to conduct clinical studies and ensure patient safety. These actions are expected to advance the search for a new Crohn's disease treatment. Additionally, thanks to technological advancements, the market for Crohn's disease treatments is growing in popularity. The leading players in the target market, for instance, are emphasizing the use of cutting-edge technology like artificial intelligence (A.I.) for drug discovery and the provision of novel treatments for Crohn's disease, which is expected to create growth opportunities for the market. However, the higher cost of this type of treatment, which includes the drug as well as other expenses, will hinder the growth of the Crohn's disease market. Additionally, developing countries like China, Russia, and India have few reimbursement policies for the treatment of Crohn's disease, which restricts the use of medications in the region.

By Type

  • Ileocolitis
  • Ileitis
  • Granulomatous Colitis
  • Gastroduodenal Crohn’s Disease
  • Jejunoileitis
  • Perianal Crohn’s Disease

By Treatment

  • Non-Surgical
    •  Corticosteroids
    •  Oral 5-Aminosalicylates
    •  Azathioprine
    •  Mercaptopurine
    •  TNF Inhibitors
    •  Methotrexate
    •  Natalizumab
    •  Vedolizumab
    •  Ustekinumab
    •  Anti-Inflammatory
    •  Immune System Suppressors
    •  Antibiotics
    •  Others
  • Surgical

By End-User

  • Hospitals & Clinics
  • Research Institutes
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the existence of numerous powerful market participants and the numerous strategic efforts they have launched in the region. Additionally, the region's improved reimbursement practices, high treatment rates, and rising prescription of novel drugs facilitate regional expansion. The region's expansion is also predicted to be fueled by continuous efforts to discover innovative therapies and supportive governmental initiatives. For instance, one of the major organizations that supports numerous clinical and translational studies to identify treatments for colitis and Crohn's disease is the Crohn's & Colitis Foundation in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Crohn’s Disease Market By Type, By Treatment, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Crohn’s Disease Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Crohn’s Disease Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Crohn’s Disease Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Crohn’s Disease Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Ileocolitis
        2. Ileitis
        3. Granulomatous Colitis
        4. Gastroduodenal Crohn’s Disease
        5. Jejunoileitis
        6. Perianal Crohn’s Disease

  • 8.   Crohn’s Disease Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Non-Surgical
         1.1. Corticosteroids
         1.2. Oral 5-Aminosalicylates
         1.3. Azathioprine
         1.4. Mercaptopurine
         1.5. TNF Inhibitors
         1.6. Methotrexate
         1.7. Natalizumab
         1.8. Vedolizumab
         1.9. Ustekinumab
         1.10.Anti-Inflammatory
         1.11.Immune System Suppressors
         1.12.Antibiotics
         1.13.Others
        2. Surgical

  • 9.   Crohn’s Disease Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals and Clinics
        2. Research Institutes
        3. Diagnostic Centers
        4. Others

  • 10.   North America Crohn’s Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
            2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Crohn’s Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Crohn’s Disease Market Analysis 2017-2022 and Forecast 2023-2031(USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Crohn’s Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Johnson and Johnson Services Inc
         1.1. Company Overview
         1.2. Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Pfizer Inc
         2.1. Company Overview
         2.2. Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Allergan
         3.1. Company Overview
         3.2. Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. AbbVie Inc
         4.1. Company Overview
         4.2. Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bayer AG
         5.1. Company Overview
         5.2. Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Amgen, Inc.
         6.1. Company Overview
         6.2. Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Takeda Pharmaceutical Company Limited
         7.1. Company Overview
         7.2. Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. UCB S.A.
         8.1. Company Overview
         8.2. Type Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ferring B.V.
         9.1. Company Overview
         9.2. Type Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Eli Lilly and Company
         10.1. Company Overview
         10.2. Type Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Hoffman-La Roche
         11.1. Company Overview
         11.2. Type Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Bristol-Myers Squibb
         12.1. Company Overview
         12.2. Type Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Boehringer Ingelheim GmbH
         13.1. Company Overview
         13.2. Type Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. GlaxoSmithKline plc
         14.1. Company Overview
         14.2. Type Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
           15. Janssen Biotech, Inc.
         15.1. Company Overview
         15.2. Type Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11